Samuel Joseph Parisi is a finance professional currently serving as Vice President, Finance and Interim Principal Accounting Officer (PAO) at Alkermes plc, a biopharmaceutical company headquartered in Dublin, Ireland.( In this role, he is responsible for key aspects of the company’s financial reporting and accounting oversight, as reflected in his designation on recent U.S. Securities and Exchange Commission Form 4 insider transaction filings.( As a named executive insider, Parisi is also one of Alkermes’ more active insiders in terms of trading activity in the company’s stock.(

Parisi’s insider filings show regular equity-based compensation and share transactions in Alkermes, with his holdings and trades disclosed through multiple financial and regulatory data platforms that list him as VP, Finance (Interim PAO) of Alkermes plc.( Publicly available sources focus primarily on his current executive position and insider trading history; detailed information about his prior career roles or formal educational background is not disclosed in standard corporate or regulatory profiles.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.